Actively Recruiting
Assessment of Sleep Quality in Patients Treated for Cancer Between 15 and 24 Years of Age
Led by Centre Hospitalier Universitaire de Nice · Updated on 2026-02-27
400
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating sleep quality in individuals who were treated for cancer during adolescence and young adulthood, between the ages of 15 and 24. This study focuses on the long-term effects of cancer treatments like chemotherapy and radiotherapy on sleep, fatigue, and related complications that may arise years after treatment. Sleep disorders are common among adolescents, and survivors often report ongoing fatigue, but the impact of cancer treatment on sleep quality in this group has not been well studied. The study involves an online survey to assess sleep quality and related factors such as anxiety, depression, and pain. Participants will complete self-administered questionnaires through the Reseau Morphee platform, which also includes a precarity scale. The study aims to identify how many participants experience moderate to severe insomnia and to explore risk factors associated with sleep disorders. Participants will provide information through this online survey, which will be used to evaluate their sleep difficulties and associated symptoms. Researchers will measure the number of patients with significant insomnia as the primary outcome and identify risk factors for sleep disorders as secondary outcomes. The study is open to patients who have completed intensive cancer treatment at least three months prior, are able to understand French, and meet other health and functional criteria. The total duration of involvement centers on completing the survey and assessments at the initial time point.
CONDITIONS
Brief Title
Assessment of Sleep Quality in Patients Treated for Cancer Between 15 and 24 Years of Age
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient treated for a cancer
- Patient aged between 15 and 24 years old at the time of the diagnosis
- Patients whom intensive treatment ended at least 3 months ago
- Patient followed in a PACAAURA cancerology center
- Life expectancy ≥ 6 months
- Karnosky index > 60%
- Patient who agrees to participate in the program and benefits from social security
- Patient able to understand, speak and read French
- No major cognitive impairment (assessed by the patient's referees)
- No sensory disability
You will not qualify if you...
- Patient unable to use informatic tools
- Known superior cognitive function disorders
- Progressive psychiatric pathology
- Drug user or alcohol abuse
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (online survey)
Duration - 1 day
Participants complete an online survey to evaluate sleep quality and associated factors such as anxiety, depression, pain, and precarity.
1 online survey session
Trial Site Locations
Total: 1 location
1
CHU de Nice
Nice, France
Actively Recruiting
Research Team
M
Meryl Horwitz, Dr
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SCREENING
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here